Protective Effect of Peroxisome Proliferator-Activated Receptor α Activation against Cardiac Ischemia-Reperfusion Injury Is Related to Upregulation of Uncoupling Protein-3

Oxidative Medicine and Cellular Longevity
Jong Wook SongYoung-Lan Kwak

Abstract

Activation of peroxisome proliferator-activated receptor α (PPARα) confers cardioprotection, while its mechanism remains elusive. We investigated the protective effect of PPARα activation against cardiac ischemia-reperfusion injury in terms of the expression of uncoupling protein (UCP). Myocardial infarct size and UCP expression were measured in rats treated with WY-14643 20 mg/kg, a PPARα ligand, or vehicle. WY-14643 increased UCP3 expression in vivo. Myocardial infarct size was decreased in the WY-14643 group (76 ± 8% versus 42 ± 12%, P<0.05). During reperfusion, the incidence of arrhythmia was higher in the control group compared with the WY-14643 group (9/10 versus 3/10, P<0.05). H9c2 cells were incubated for 24 h with WY-14643 or vehicle. WY-14643 increased UCP3 expression in H9c2 cells. WY-14643 decreased hypoxia-stimulated ROS production. Cells treated with WY-14643 were more resistant to hypoxia-reoxygenation than the untreated cells. Knocking-down UCP3 by siRNA prevented WY-14643 from attenuating the production of ROS. UCP3 siRNA abolished the effect of WY-14643 on cell viability against hypoxia-reoxygenation. In summary, administration of PPARα agonist WY-14643 mitigated the extent of myocardial infarction and inciden...Continue Reading

References

Oct 1, 1992·Physiological Reviews·G J van der VusseR S Reneman
Jun 1, 1984·Journal of Molecular and Cellular Cardiology·A S Manning, D J Hearse
Mar 22, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·M E YoungH Taegtmeyer
Jun 12, 2002·Journal of Molecular and Cellular Cardiology·G C RodrigoN B Standen
Jun 28, 2002·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Nicole S WaymanChristoph Thiemermann
Jan 29, 2003·Proceedings of the National Academy of Sciences of the United States of America·Brian N FinckDaniel P Kelly
Jul 12, 2003·Circulation Research·Yasushi TeshimaEduardo Marbán
Mar 18, 2004·Antioxidants & Redox Signaling·Hajime Otani
Aug 12, 2004·Free Radical Biology & Medicine·Martin D BrandNadeene Parker
Nov 16, 2004·Lancet·Andrew J MurrayKieran Clarke
Mar 2, 2005·Nature Reviews. Molecular Cell Biology·Stefan KraussBradford B Lowell
Aug 5, 2005·The Journal of Biological Chemistry·Christopher J McLeodMichael N Sack
Sep 13, 2005·American Journal of Physiology. Heart and Circulatory Physiology·Nandakumar SambandamGary D Lopaschuk
Nov 15, 2005·The Journal of Clinical Investigation·Fadi G AkarBrian O'Rourke
Mar 3, 2006·The Journal of Clinical Investigation·Philippe LefebvreBart Staels
Apr 9, 2008·Physiological Reviews·Elizabeth Murphy, Charles Steenbergen
May 9, 2008·Journal of Molecular and Cellular Cardiology·Jose A Madrazo, Daniel P Kelly
Jan 20, 2009·American Journal of Physiology. Heart and Circulatory Physiology·Aliaksandr A BulhakJohn Pernow
Mar 5, 2013·American Journal of Physiology. Heart and Circulatory Physiology·Cevher OzcanRaymond R Russell

❮ Previous
Next ❯

Citations

Nov 16, 2017·Journal of Gastroenterology and Hepatology·Guolin LiFrank J Gonzalez
Nov 5, 2017·Biochemical Society Transactions·Bernd Gesslbauer, Valery Bochkov

❮ Previous
Next ❯

Methods Mentioned

BETA
transfection
PCR
electrophoresis
flow cytometry

Software Mentioned

CellQuestPro
SAS

Related Concepts

Related Feeds

Bioinformatics in Biomedicine

Bioinformatics in biomedicine incorporates computer science, biology, chemistry, medicine, mathematics and statistics. Discover the latest research on bioinformatics in biomedicine here.

Autophagy & Aging: Inhibitors

The feed focuses on the role of nuclear export inhibitors and their effect on autophagy and the aging process.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.